Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer

NCT02725424 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: S-1
DRUG: Trastuzumab
DRUG: Oxaliplatin
DRUG: Docetaxel

Sponsor

Chinese Academy of Medical Sciences